Directory
Manuel Portero Otin

Manuel Portero Otin

Degree: PhD

973 702 408
manuel.portero(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/B-7122-2009

Groups

Publications

  • PorteroOtin, M; Pamplona, R; Bellmunt, MJ; Bergua, M; Prat, J

    Glycaemic control and in vivo non-oxidative Maillard reaction: urinary excretion of pyrraline in diabetes patients.

    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 27 767-773. .

    [doi:10.1046/j.1365-2362.1997.1900740.x]

  • PORTERO OTIN, MANUEL; Pamplona R; Bellmunt MJ; Bergua M; Nagaraj RH; Prat J

    Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivo.

    LIFE SCIENCES 60 279-287. .

  • PorteroOtin, M; Pamplona, R; Bellmunt, MJ; Bergua, M; Nagaraj, RH; Prat, J

    Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivo

    LIFE SCIENCES 60 279-287. .

    [doi:10.1016/S0024-3205(96)00628-5]

  • Bellmunt, MJ; PORTERO, M; Pamplona, R; Cosso, L; Odetti, P; Prat, J

    Pentosidine: ageing marker for lung collagen

    Journal Of Physiology-London 493P 62-62. .

  • PORTERO, M; Pamplona, R; Bellmunt, MJ; Nagaraj, RH; Monnier, VM; Prat, J

    Ageing of proteins: Urinary excretion for pyrraline (epsilon-2-(formyl-5-hydroxymethyl-pyrrol-1-yl)-L-norleucine) formed during Maillard reaction in vivo

    Journal Of Physiology-London 493P 60-60. .

  • Nagaraj, RH; PorteroOtin, M; Monnier, VM

    Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes

    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 325 152-158. .

    [doi:10.1006/abbi.1996.0019]

  • Monnier, VM; Nagaraj, RH; PorteroOtin, M; Glomb, M; Elgawish, AH; Sell, DR; Friedlander, MA

    Structure of advanced Maillard reaction products and their pathological role

    NEPHROLOGY DIALYSIS TRANSPLANTATION 11 20-26. .

  • Bellmunt MJ; Portero M; Pamplona R; Cosso L; Odetti P; Prat J

    Evidence for the Maillard reaction in rat lung collagen and its relationship with solubility and age.

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS 1272 53-60. .

  • Bellmunt, MJ; PORTERO, M; Pamplona, R; COSSO, L; ODETTI, P; Prat, J

    EVIDENCE FOR THE MaILLaRD REaCTION IN RaT LUNG COLLaGEN aND ITS RELaTIONSHIP WITH SOLUBILITY aND aGE

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1272 53-60. .

    [doi:10.1016/0925-4439(95)00069-G]

  • Pamplona, R; Bellmunt, MJ; PORTERO, M; RIBA, D; PRAT, J

    CHROMaTOGRaPHIC EVIDENCE FOR aMaDORI PRODUCT FORMaTION IN RaT-LIVER aMINOPHOSPHOLIPIDS

    LIFE SCIENCES 57 873-879. .

    [doi:10.1016/0024-3205(95)02020-J]

  • Bellmunt, MJ; PORTERO, M; Pamplona, R; MUNTANER, M; PRAT, J

    Age-related fluorescence in rat lung collagen.

    Lung 173 177-185. .

  • PorteroOtin, M; NAGARAJ, RH; MONNIER, VM

    CHROMaTOGRaPHIC EVIDENCE FOR PYRRaLINE FORMaTION DURING PROTEIN GLYCaTION IN-VITRO aND IN-VIVO

    Biochimica Et Biophysica Acta-Protein Structure And Molecular Enzymology 1247 74-80. .

    [doi:10.1016/0167-4838(94)00209-Y]

Projects

  • SEED-ALS: Synergizing Efforts to Develop and Accelerate Breakthroughs in ALS Research
  • Natural microbicides from rice against current and emerging infectious diseases
  • Humanised mouse models to study ATG4B cryptic exon involvement in ALS pathogenesis and its potential as disease biomarker (Hum4ALS)
  • Targeting cryptic exons as biomarkers and ALS therapy
  • Desregulacion de TDP-43,eje clave en la ELA: Caracterización de firmas lipidómicas, transcriptómicas y autofágicas en muestras específicas de pacientes para biomarcadores y reposicionamiento
  • Comprehensive Roadmap and Preclinical Evaluation of Antisense Oligonucleotides (ASOs) Regulatory Development and Toxicological Assessment for ALS Treatment
  • The role of defects in mitochondria-associated ER membranes (MAM) to Amyotrophic Lateral Sclerosis
  • Perspectivas clínicas de la biología de sistemas aplicada al análisis de placas carotídeas humanas: ILER-CAROTID
  • Metabolismo lipidico intracelular, procesamiento de ARNm y estrés celular en la encrucijada de la fisiopatología de la esclerosis lateral amiotrófica
  • Identification of compounds for inhibition of ACE2 membrane expression
  • Reposicionamiento terapéutico dirigido a inhibición de expresión de ACE2 y de proteolisis de trímero S viral
  • Determinació de components bioactius derivats de la microbiota mitjançant micromostreig